PT - JOURNAL ARTICLE AU - Irving Cancino-Muñoz AU - Mariana G. López AU - Manuela Torres-Puente AU - Luis M. Villamayor AU - Rafael Borrás AU - María Borrás-Máñez AU - Montserrat Bosque AU - Juan J. Camarena AU - Caroline Colijn AU - Ester Colomer-Roig AU - Javier Colomina AU - Isabel Escribano AU - Oscar Esparcia-Rodríguez AU - Francisco García-García AU - Ana Gil-Brusola AU - Concepción Gimeno AU - Adelina Gimeno-Gascón AU - Bárbara Gomila-Sard AU - Daminana González-Granda AU - Nieves Gonzalo-Jiménez AU - María Remedio Guna-Serrano AU - José Luis López-Hontangas AU - Coral Martín-González AU - Rosario Moreno-Muñoz AU - David Navarro AU - María Navarro AU - Nieves Orta AU - Elvira Pérez AU - Josep Prat AU - Juan Carlos Rodríguez AU - Ma. Montserrat Ruiz-García AU - Hermelinda Vanaclocha AU - Valencia Region Tuberculosis Working Group AU - Iñaki Comas TI - Population-based sequencing of <em>Mycobacterium tuberculosis</em> reveals how current population dynamics are shaped by past epidemics AID - 10.1101/2022.01.24.22269736 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.24.22269736 4099 - http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269736.short 4100 - http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269736.full AB - Background Transmission has been proposed as a driver of tuberculosis (TB) epidemics in high-burden regions, with negligible impact in low-burden areas. Genomic epidemiology can greatly help to quantify transmission in different settings but the lack of whole genome sequencing population-based studies has hampered its use to compare transmission dynamics and contribution across settings.Methods We generated an additional population-based sequencing dataset from Valencia Region, a low burden setting, and compared it with available datasets from different TB settings to reveal heterogeneity of transmission dynamics and its public health implications. We sequenced the whole genome of 785 M. tuberculosis strains and linked genomes to patient epidemiological data. We applied a pairwise distance clustering approach and phylodynamics methods to characterize transmission events over the last 150 years, in Valencia, Spain (low burden), Oxfordshire, United Kingdom (low burden) and a high-burden (Karonga, Malawi).Results Our results revealed high local transmission in the Valencia Region (47.4% clustering), in contrast to Oxfordshire (27% clustering), and similar to a high-burden setting like Malawi (49.8% clustering). By modelling times of the transmission events, we observed that settings with high transmission are associated with uninterrupted transmission of strains over decades, irrespective of burden.Conclusions Our results underscore significant differences in transmission between TB settings even with similar burdens, reveal the role of past epidemic in on-going TB epidemic and highlight the need for in-depth characterization of transmission dynamics and specifically-tailored TB control strategies.Funding European Research Council under the European Union’s Horizon 2020 research and innovation program (Grants 638553-TB-ACCELERATE, 101001038-TB-RECONNECT), and Ministerio de Ciencia e Innovación (Spanish Government, SAF2016-77346-R and PID2019-104477RB-I00)Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis manuscript does not involve clinical trialsFunding StatementThis project received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (Grants 638553-TB-ACCELERATE, 101001038-TB-RECONNECT) and by projects SAF2016-77346-R and PID2019-104477RB-I00 from Ministerio de Ciencia (Spanish Government).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval for the study was given by the Ethics Committee for Clinical Research from the Valencia Regional Public Health Agency (Comité Ético de Investigación Clínica de la Dirección General de Salud Pública y Centro Superior de Investigación en Salud Pública). Informed consent was waived on the basis that TB detection forms part of the regional compulsory surveillance program of communicable diseases.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequences were upload to ENA under the project numbers PRJEB29604 and PRJEB38719. Sequences detail, and associated information is detailed in Supplemental Table 1